Frazier Life Sciences IX, L.P.'s Net Worth

$249 Million

Estimate Recalculated Sep 18, 2024 05:40PM EST

Who is Frazier Life Sciences IX, L.P.?

Frazier Life Sciences IX, L.P. has an estimated net worth of $249 Million. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., and Passage BIO, Inc..

SEC CIK

Frazier Life Sciences IX, L.P.'s CIK is 0001720320

Past Insider Trading and Trends

2020 was Frazier Life Sciences IX, L.P.'s most active year for acquiring shares with 7 total transactions. Frazier Life Sciences IX, L.P.'s most active month to acquire stocks was the month of September. 2020 was Frazier Life Sciences IX, L.P.'s most active year for disposing of shares, totalling 6 transactions. Frazier Life Sciences IX, L.P.'s most active month to dispose stocks was the month of February. 2019 saw Frazier Life Sciences IX, L.P. paying a total of $47,325,317.00 for 5,973,183 shares, this is the most they've acquired in one year. In 2019 Frazier Life Sciences IX, L.P. cashed out on 26,288,940 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.92M
$16.00
—
1.92M
Oct 20
Form 3
—
0
—
—
0
No matching records found

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.00%
-1.46M
—
—
5.83M
Jun 12
Form 4
+49.33%
2.41M
$16.86
$40,575,317.00
7.28M
Oct 29
Form 3
—
0
—
—
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $41.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.57M
$15.00
—
3.57M
Jul 22
Form 3
—
0
—
—
0
No matching records found

Passage BIO, Inc. (PASG) Snapshot price: $0.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5.01M
$18.00
—
5.01M
Mar 3
Form 3
—
0
—
—
0
No matching records found